simplex virus types 1 and 2 [HSV1, HSV2], green monkey simian agent 8, baboon herpesvirus 2 [HVP2], and macaque B virus [BV]) was developed utilizing the polymerase chain reaction (PCR). PCR primers were located in conserved regions of the gene encoding the glycoprotein B, which flanks an intervening region that is highly divergent among the 5 viruses. Amplified PCR products from the 5 viruses were readily differentiated by their unique restriction enzyme digestion patterns. No variation in digestion patterns was noted among strains of HSV1, HSV2, or HVP2. One clinical isolate of BV exhibited variation in a single restriction site, but its overall restriction pattern remained typical of BV. This method (PCR/RFLP) allowed the presence of herpesvirus DNA in clinical swabs from primates to be readily detected and the virus unambiguously identified.
Cercopithecine herpesvirus 1 (Herpesvirus simiae, monkey B virus; BV) is common in macaques (Macaca spp.), causing mild disease similar to that produced in humans by the herpes simplex viruses (HSV1, HSV2). 8, 16, 30, 32, 34 BV is however a major Zoonotic concern in primate colonies that house macaques. When the virus is transmitted to humans by scratches or bites, severe and frequently fatal neurologic disease results if the infection is not rapidly identified and treatment initiated immediately. 2, 4, 12, 21 Although originally isolated from African green monkeys (Cercopithecus aethiops), 9, 18 simian agent 8 (SA8) is common in both wild and captive baboons (Papio spp.). 6, 13, 14, 17, 49 Recent studies indicate that the baboon virus is closely related to but distinct from SA8; it has been provisionally designated H. papio 2 (HVP2) to distinguish it from SA8. 6 Although its pathogenicity for humans is not known, HVP2 outbreaks in baboon breeding colonies have been associated with genital infections of adults and an increased incidence of stillbirths and hydrocephaly in newborns. 17 Identification of viruses isolated from monkeys or from humans suspected of having been infected with a simian herpesvirus is usually done by virus isolation, a procedure requiring a minimum of 2-4 days for results. Furthermore, additional testing is necessary to specifically identify the virus once isolated, a process involving additional time and resources. Virus identification is complicated by the close antigenic and genetic relatedness of HSV1, HSV2, SA8, HVP2, and BV 8, 10, 13, 27, 28 and by the danger of working with infec-tious BV, which is a Class 4 pathogen. Nonetheless, rapid detection and confirmation of suspect human BV infections is necessary for appropriate case management. Comparison of restriction fragment length polymorphism (RFLP) patterns of DNA prepared from isolated virus 11,29 and competition enzyme-linked immunosorbent assays (ELISAs) 15 have been described for discrimination between BV and the HSVs, but each is complex and involves handling of infectious virus.
Recently, application of the sensitive polymerase chain reaction (PCR) for detection of primate herpesviruses has been described. 22, 23, 25 Although differentiation of PCR products from BV, HSV1, and HSV2 has been described, the methods involve use of multiple restriction enzyme digests. These tests have also not been applied to identification of HVP2 and SA8 or to their differentiation from BV or HSV.
In this communication, we describe a PCR-based test that takes advantage of the presence of regions of alternating highly conserved and widely divergent DNA sequences in the gene encoding the glycoprotein B (gB) of primate -herpesviruses. The test is rapid, sensitive, and reliable for the detection and discrimination of HSV1, HSV2, SA8, HVP2, and BV.
Materials and methods
Viruses and cells. The KOS strain of HSV1, the 186 strain of HSV2, the B264 strain of SA8 originally isolated from an African green monkey, 18 and the rhesus monkey E2460 strain of BV were used as standard viruses. Additional isolates of HSV1 were from clinical human cases of recurrent oral lesions (CA, An, BK), encephalitis (IS), or genital lesions (KM 119). HSV1 strains 8405336 (isolated from a gorilla with recurrent genital lesions 7 ) and F (an established laboratory strain) were also used. Isolates of HVP2 were obtained from colony baboons (Papio cynocephalus) (unpublished). 17 Field isolates of HSV2 were all isolated from clinical human cases of genital herpes. DNA from clinical BV isolates obtained from various primate centers in the US was generously provided by Dr. J. K. Hilliard (Southwest Foundation for Biomedical Research [SFBR], San Antonio, TX). Propagation and quantitation of viruses and purification of viral DNA from infected cells have been described previously. 5 Collection and processing of clinical specimens. Clinical samples were obtained from 3 sources: oropharyngeal swabs and swabs of visible recurrent lip lesions on human volunteers; oral and genital swabs of asymptomatic baboons (P. anubis, P. ursinus) housed in a closed breeding colony located at the University of Oklahoma Health Sciences Center (OUHSC) in Oklahoma City, OK; and clinical swabs submitted to the BV reference laboratory at SFBR. Cotton-tipped applicators were used as swabs and placed in 1-ml transport medium (Dulbecco's modified Eagle medium supplemented with 2% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin, and 10 µg/ml amphotericin B). Samples were tested for infectious virus by inoculating 500 µl onto subconfluent Vero cells. Cultures were observed for signs of cytopathic effect for 5 days.
For PCR detection of viral DNA in clinical samples, 100 µl of sample was combined with 100 µl of digestion buffer (50 mM Tris HCl, pH 8.0, 1 mM ethylenediaminetetraacetic acid (EDTA), 0.5% Tween 20) and 49 µg proteinase K. Samples were digested overnight at 42 C, heated to 100 C for 10 min, and immediately placed on ice until the PCR was set up using 20 µl of the sample digest.
PCR conditions. A PCR master mix consisted of PCR buffer, a MgCL 2 , dNTP, and Taq polymerase. This mix was stored in 25 µl aliquots at -20 C. PCRs were set up by adding to each tube of master mix the target DNA, dimethyl sulfoxide (DMSO), and water to bring the final volume to 50 µl. The final concentrations of reagents were PCR buffer, 1 x ; dNTPs, 100 mM each; MgCl 2 , 2.5 mM; primers, 0.5 µM each; DMSO, 10%; and Taq polymerase, 2.5 units.
PCRs were run using 40 cycles of denaturation at 94 C for 60 sec, annealing at 48 C for 60 sec, and elongation at 72 C for 120 sec in a thermocycler. a Final extension of products was carried out at 72 C for 4 min. Except where noted otherwise, 10 µl was run on agarose gels to detect PCR products.
For restriction digestion, PCR products were either purified using Wizard PCR Preps b or precipitated with ammonium acetate/ethyl alcohol. Samples were resuspended in 10 mM Tris/0.1 mM EDTA, digested for 1 hr at 37 C with Hae3, and run on 6% acrylamide gels using standard procedures. 20 Gels were stained with ethidium bromide (EtBr) and photographed under UV light. pUC19 DNA cut with Hha1 was used as a size standard.
Results
The amino acid sequence of gB is conserved in most -herpesviruses. The basic structural features of gB are shown in Figure 1 . Based on multiple alignment of predicted amino acid sequences of 16 different -herpesvirus gB polypeptides, distinct regions of highly conserved (C1, C2, C3) and highly divergent (D1, D2, D3, D4) sequence are apparent. Alignment of the corresponding DNA sequences for the gB (UL27) genes of HSV1, HSV2, SA8, BV, and HVP2 gave similar results, with the same divergent and conserved regions readily apparent (not shown). Based on the aligned primate virus gB DNA sequences, several sets of PCR primers were designed that 1) were located in the highly conserved C1 and C2 regions, 2) flanked the divergent D2 region, 3) required minimal sequence degeneracy for homology with all 5 virus sequences, and 4) did not have extremely high G + C content or intra-and/ or interprimer sequence homology. Several such primer sets were tested, but the B3/B4 and B9/B10 sets gave the most consistent and usable results. All results presented here were generated using these primer sets.
The B3/B4 and B9/B10 primer sequences and predicted sizes of the PCR products expected for each virus based on GenBank DNA sequence data are listed in Table 1 . Both primer sets amplified products of the expected size from DNA of all 5 primate herpesviruses ( Fig. 2A ). Because sizes of the products varied by only 2-4%, it was not possible to differentiate PCR products from different viruses based on size alone, even using high-resolution gels. The B3/B4 primer set also amplified sequences from the South American a-herpesvirus HVS1 (H. saimiri 1 8 ) but did not amplify DNA of the bovine herpesvirus 1 or the porcine respiratory virus -herpesviruses (not shown).
Computer prediction of restriction fragment sizes from PCR products indicated that either Hae3 or Hha1 should produce differentiable cleavage patterns for each of the 5 viruses. The expected sizes of Hae3 fragments for each virus are listed in Table 2 . Hae3 digestion patterns of PCR products amplified from the 5 primate -herpesviruses using the B3/B4 and B9/B10 primer sets are shown in Figures 2B and 2C , respectively. The sizes of fragments visible on polyacrylamide gels corresponded directly with those predicted. Although the products generated with the B3/B4 primer set gave more distinct RFLP patterns for different viruses, patterns for B9/B10 primer products were also differentiable by Hae3 digestion. This approach (PCR/RFLP) thus permitted products amplified from different viruses to be easily distinguished from each other.
Previous studies have demonstrated the ability to differentiate individual strains of a virus based on RFLP patterns of viral DNA. 11, 24, 29 Because the ability of PCR/ RFLP to differentially identify the 5 primate viruses relies on cutting PCR products with a frequent-cutting (4-bp recognition sequence) restriction enzyme to generate a reproducible RFLP pattern, nucleotide variation in the amplified region of the gB DNA sequences among individual strains of a virus could affect reliability of the test. This problem was of particular concern because the amplified product represents a highly divergent region of the gB open reading frame.
This potential problem was first addressed by comparison of all gB DNA sequences available for different HSV1 and HSV2 strains in the GenBank DNA sequence database. No sequence variation was apparent in the region amplified by PCR. To confirm this apparent lack of strain variation within the amplified region, multiple clinical isolates of HSV1, HSV2, BV, and HVP2 were tested using the PCR/RFLP procedure (no additional strains of SAS from green monkeys were available for testing). As shown in Figure 3A , no variability was detected among 8 strains of HSV1, despite the isolates being derived from widely variant sources. Similarly, no variation was observed among 5 clinical isolates of HSV2 (not shown), 5 HVP2 baboon isolates that were all distinct from SA8 (Fig. 3B) , and 5 BV isolates (Fig. 3C) . Thus, strain variation in the gB D2 region does not appear to be a problem effecting reliability of the PCR/RFLP test.
The sensitivity of the PCR amplification was assessed using purified viral DNA and infected cell DNA. Depending on the nature of the DNA preparation, products amplified from 0.1-10 ng of template DNA were directly visible on EtBr-stained agarose gels. Similarly, PCR products amplified from as few as 10 infected cells were visible on EtBr-stained gels (not shown).
PCR/RFLP detection and differential identification of viral DNA in clinical samples was tested using the B9/B10 primer set. Several human oropharyngeal swabs and swabs of recurrent labial lesions were screened by PCR. Amplification products were detected in 417 swabs of visible recurrent lip lesions and 0/3 oropharyngeal swabs from asymptomatic volunteers. Digestion of all 4 PCR products with Hae3 gave typical HSV1 patterns. Virus was isolated from 3/4 of the PCR-positive samples and 0/6 PCR-negative samples. All 3 virus isolates were identified as HSV1 based on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of infected cell proteins and their immunoreactivity in western blots (not shown).
Wild-caught baboons newly imported into the OUHSC colony from Kenya (P. anubis) and South Africa (P. ursinus) were screened by PCR and virus isolation of throat and genital swabs. No lesions were visible on any individuals on occasions when swabs were collected for PCR testing. Of 62 samples tested (from 31 individual animals), none were positive by PCR or virus isolation. Based on ELISA screening of these animals, approximately 94% (29/31) were infected with HVP2. Additional clinical swab samples from humans and macaques submitted to the B virus reference laboratory at SFBR for testing were also tested by PCR/RFLP. Of these, 2/3 human samples, 2/2 SA8 lab controls, and 5/7 macaque samples were positive by PCR. Virus isolation from these samples gave similar results, the only discrepancy being detection of viral DNA by PCR in 1 human sample, which was negative by virus isolation. In addition, a virus (designated OU-76) was isolated from an infant in the OUHSC resident breeding colony that was recovering from a respiratory infection contracted 1-2 weeks earlier. Its mother had recently recovered from hind limb paresis and was seropositive for HVP2. Identification of all virus isolates was confirmed by SDS-PAGE analysis of viral proteins.
RFLP analysis of PCR products from positive clinical samples was used to identify virus present in them. Comparison of patterns from various clinical samples with those of reference viruses allowed differentiation of different viruses present in the clinical specimens ( Fig. 4) . PCR products from lip lesions of humans were with Sac2 or by hybridization with a BV-specific raall typed as HSV1 (lanes 6, 8, 9 ). The PCR product diolabeled oligonucleotide probe. No attempt was made from an OUHSC colony baboon isolate (OU-76) was to differentiate HSV1 from HSV2 or to detect and/or identified as HVP2 (lane 7), and 2 SA8 lab controls differentiate SA8 or HVP2. Recently, this PCR test from SFBR were confirmed as such (lanes 10, 11). was modified to include differentiation of HSV1 and Three of 4 PCR products from macaque samples gave HSV2. 23 However, differentiation of HSV1, HSV2, and RFLP patterns typical of BV (lanes 13-15). However, BV relies on the presence/absence of a single restriction 1 of the PCR products from a macaque sample dis-site in each PCR product and use of 2 different restricplayed a variant RFLP (lane 12). This pattern was tion enzymes. missing the largest 107-bp Hae3 fragment and had Another PCR test for detection of BV in clinical instead 2 additional fragments of approximately 50 samples was also recently described. 25 The investigaand 57 bp, suggesting the presence of an additional tors used primer sequences located in the noncoding Hae3 site in the amplified fragment of this particular intergenic region between the US5 (glycoprotein J) and BV isolate.
US6 (glycoprotein D) coding sequences. 1 Although these primers specifically amplified DNA from BV isolates Discussion of cynomolgus monkeys, they failed to detect BV isolates from rhesus monkeys, SA8, HSV1, and HSV2. Detection and differentiation of primate a-herpes-Comparison of homologous DNA sequences from a viruses has been a time-and labor-intensive process cynomolgus BV isolate 1 with that of a rhesus isolate made more difficult by the extensive genetic relatedof BV (unpublished) revealed a number of nucleotide ness of these viruses . 8,J3 Antigenic cross-reactivity of differences in the intergenic sequences used previously 25 most viral polypeptides in particular has impeded defor primer and probe sequences. These sequence difvelopment of reliable, sensitive serodiagnostic ferences are substantial enough to preclude both amtests. 3, 15, 27, 28 In an attempt to circumvent the antigenic plification of rhesus BV DNA by the primers and hycross-reactivity of these viruses, development of dibridization with the probe used previously thereby exagnostic tests based on detection of viral DNA has plaining the specificity of the assay for cynomolgus BV been explored. 22, 23, 25 isolates.
Several PCR tests for detection of BV have been
The PCR-based test used in the present study is described. Primer sequences located in a capsid protein capable of both detecting all simian -herpesviruses gene (UL28) were used to amplify DNA of HSV1, representing potential Zoonotic hazards (SA8, HVP2, HSV2 and BV. 22 PCR products derived from BV were BV) and differentiating these viruses from each other then identified either by their susceptibility to cleavage and from the human HSV1 and HSV2. The occurrence For virus identification, PCR products were digested with Hae3 and run on a 6% acrylamide gel. PCR products amplified from HSV1, HSV2, SAS, HVP2, and BV reference strains are shown in lanes 1, 2, 6, 9, and 11, respectively. PCR products amplified from clinical samples were from recurrent human labial lesions (lanes 3-5), SFBR SA8 lab controls (lanes 7, 8) , an OUHSC baboon isolate OU1-76 (lane 10), and macaque samples submitted to . For reference, the sizes of some restriction fragments are indicated in base pairs at left and right. of small, discrete regions of highly divergent sequence within the otherwise strongly conserved gB coding sequence provided an ideal basis for development of such a PCR test. The high G + C content of all these gB open reading frames, and the divergent D2 region in particular, does present problems both in sequencing and PCR amplification. However, these problems were overcome by addition of DMSO to PCR reaction mixtures and use of higher temperatures for annealing and extension reactions. Although the B9/B10 primer set amplifies a shorter sequence than does the B3/B4 primer pair, the B9/B10 set was neither more nor less reliable or sensitive than was the B3/B4 pair. Because the RFLP is more distinct for the different viruses using the B3/B4 primer set, this set may be preferred for routine use.
A major concern in using PCR amplification/RFLP of a divergent region of a conserved gene is the potential for sequence variation in the amplified region with consequent variation in RFLPs. Computer analysis of all HSV1 and HSV2 gB gene sequences deposited in GenBank (6 HSV1, 6 HSV2) did not reveal any potential variation in RFLPs with these PCR primer sets.
Similarly, testing of field isolates of HSV1 and HSV2 from widely variant sources yielded invariant RFLPs for these 2 viruses. This technique has been applied for identification of viruses isolated from baboons of 3 different breeding colonies, and no variation in RFLPs for HVP2 strains has been observed despite RFPL variation among different strains based on analysis of whole genomic DNA. Despite this apparent lack of variability in RFLPs for HSV1, HSV2, and HVP2, RFLP variation was observed in 1 clinical BV isolate. The significance of this variation is not known. Although BV strains may display significantly more strain variation in sequence in this region of the gB gene, it is equally possible that differences among BV isolates may be related to the different macaque species harboring the virus. This variation is currently being investigated.
Although the majority of macaques are infected with BV, shedding of virus by seropositive animals has only rarely been detected using virus isolation. 31, 33 Availability of a rapid, sensitive PCR-based test for virus detection will provide a more sensitive assay with which to identify monkeys that pose a potential zoonotic dan-ger to personnel working with them. In addition, identification of infected animals should aid in the development of virus-free breeding colonies. In a situation 14. where infection of humans with a monkey virus is suspected, tests such as that described here can provide 15. rapid detection of virus in wound sites or lesions and unambiguous identification of any -herpesvirus detected. Virus detection is particularly important because humans are frequently infected with HSV1 and/ or HSV2, 26 viruses.
